(0.02%) 5 309.25 points
(0.05%) 40 165 points
(0.04%) 18 512 points
(1.68%) $82.72
(0.12%) $1.720
(0.80%) $2 230.50
(-0.22%) $24.70
(0.38%) $913.15
(0.33%) $0.926
(0.57%) $10.83
(0.10%) $0.792
(-0.08%) $92.36
Live Chart Being Loaded With Signals
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure...
Stats | |
---|---|
Today's Volume | 301 687 |
Average Volume | 90 759.00 |
Market Cap | 46.48M |
EPS | €0 ( 2023-02-09 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -1.120 |
ATR14 | €0.0170 (1.15%) |
Volume Correlation
Sequana Medical NV Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sequana Medical NV Correlation - Currency/Commodity
Sequana Medical NV Financials
Annual | 2022 |
Revenue: | €922 687 |
Gross Profit: | €718 090 (77.83 %) |
EPS: | €-1.350 |
Q2 | 2023 |
Revenue: | €384 173 |
Gross Profit: | €-1.94M (-505.82 %) |
EPS: | €-0.650 |
Q1 | 2023 |
Revenue: | €192 087 |
Gross Profit: | €147 851 (76.97 %) |
EPS: | €-0.330 |
Q4 | 2022 |
Revenue: | €458 241 |
Gross Profit: | €-2.45M (-534.16 %) |
EPS: | €-0.670 |
Financial Reports:
No articles found.
Sequana Medical NV
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators